Evidence map›Paper›PMID 32611409›Full record

ArticleBMC infectious diseases2020

Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan.

Tauseef Ahmad, Muhammad Ayub Jadoon, Muhammad Khan, Haroon, Muhammad Mumtaz Khan, Akbar Hussain, Taha Hussein Musa, Muhammad Waqar, Eyasu Ejeta, Manoochehr Karami and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Novel Mutations in MPT64 Secretory Protein ofInternational journal of environmental research and public health · 2023
    Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 7 countries.

Tauseef AhmadDepartment of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China. tauseef.ahmad@hu.edu.pk.ORCID https://orcid.org/0000-0001-8793-273X
Muhammad Ayub JadoonDepartment of Microbiology, Abbottabad University of Science and Technology Abbottabad, Abbottabad, Khyber Pakhtunkhwa, Islamic Republic of Pakistan.
Muhammad KhanDepartment of Genetics, Laboratory of Human Genetics, Hazara University Mansehra, Dhodial, 21300, Khyber Pakhtunkhwa, Islamic Republic of Pakistan.
HaroonCollege of Life Sciences, Northwest University, Xian, 710069, China.
Muhammad Mumtaz KhanDepartment of Public Health, University of Haripur, Haripur, Khyber Pakhtunkhwa, Islamic Republic of Pakistan.
Akbar HussainDepartment of Medical Microbiology, Dalian Medical University, 9 Western Section Lvshun South Road, Lvshunkou District, Dalian, Liaoning, China.
Taha Hussein MusaDepartment of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China.
Muhammad WaqarGenome Centre for Molecular Based Diagnostics and Research Centre, Cl-25 Block B Al-Sudais Plaza Abdalian Cooperative Society, Lahore, Islamic Republic of Pakistan.
Eyasu EjetaDepartment of Medical Laboratory Sciences, College of Health Sciences, Wollega University, Nekemte, Ethiopia.
Manoochehr KaramiModeling of Noncommunicable Diseases Research Center, Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Kefyalew Addis AleneFaculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Hui JinDepartment of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China. jinhui_hld@163.com.
Hazara University · PKAbbottabad University of Science and Technology · PKAustralian National University · AUCentre of Excellence in Molecular Biology · PKDalian Medical University · CNHamedan University of Medical Sciences · IRNorthwest University · CNSoutheast University · BDSoutheast University · CNWollega University · ET

Funding

National Natural Science Foundation of China 81573258
6 · The paper itself

Abstract

backgroundGlobally, tuberculosis (TB) remains the leading cause of death from a single infectious disease. TB treatment outcome is an important indicator for the effectiveness of a national TB control program. This study aimed to assess treatment outcomes of TB patients and its determinants in Batkhela, Khyber Pakhtunkhwa, Pakistan.

methodsA retrospective cohort study was designed using all TB patients who were enrolled at District Head Quarter (DHQ) Hospital Batkhela, Pakistan, from January 2011 to December 2014. A binary logistic regression models were used to identify factors associated with successful TB treatment outcomes defined as the sum of cure and completed treatment.

resultsA total of 515 TB patients were registered, of which 237 (46%) were males and 278 (53.98%) females. Of all patients, 234 (45.44%) were cured and 210 (40.77%) completed treatment. The overall treatment success rate was 444 (86.21%). Age 0-20 years (adjusted odds ratio, AOR = 3.47; 95% confidence interval, CI) = 1.54-7.81; P = 0.003), smear-positive pulmonary TB (AOR) = 3.58; 95% CI = 1.89-6.78; P = < 0.001), treatment category (AOR = 4.71; 95% CI = 1.17-18.97; P = 0.029), and year of enrollment 2012 (AOR = 6.26; 95% CI = 2.52-15.59; P = < 0.001) were significantly associated with successful treatment outcome.

conclusionsThe overall treatment success rate is satisfactory but still need to be improved to achieve the international targeted treatment outcome. Type of TB, age, treatment category, and year of enrollment were significantly associated with successful treatment outcomes.

Indexed as

AdolescentAdultAntitubercular AgentsArmed ConflictsChildChild, PreschoolFemaleHumansInfantInfant, NewbornLogistic ModelsMaleMiddle AgedMycobacterium tuberculosisOdds RatioPakistanAntitubercular AgentsPakistanTreatment outcomeTuberculosis

Identifiers

PMID32611409
PMCPMC7329461
OpenAlexW3039562922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.